{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:59:42Z","timestamp":1780822782171,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002784","name":"Canada Excellence Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Social Science &amp; Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.socscimed.2025.118697","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:25:45Z","timestamp":1760743545000},"page":"118697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["\u201cTrying to get down here when the dealer's closer\u201d: Place and participation in clinical trials for substance use disorders"],"prefix":"10.1016","volume":"387","author":[{"given":"Kaitlyn","family":"Jaffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Jutras-Aswad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-8891","authenticated-orcid":false,"given":"Lindsey","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.socscimed.2025.118697_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0208410","article-title":"Establishing trust in HIV\/HCV research among people who inject drugs (PWID): insights from empirical research","volume":"13","author":"Abadie","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.socscimed.2025.118697_bib59","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/10826080802483936","article-title":"Supervised methadone consumption: Client issues and stigma","volume":"44","author":"Anstice","year":"2009","journal-title":"Subst. Use Misuse"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118697_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1747-597X-9-44","article-title":"Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study","volume":"9","author":"Ayres","year":"2014","journal-title":"Subst. Abuse Treat. Prev. Pol."},{"issue":"5","key":"10.1016\/j.socscimed.2025.118697_bib54","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/ADM.0000000000000772","article-title":"Participants\u2019 treatment perspectives on a clinical trial on the use of extended-release naltrexone for substance use disorders: Considerations for future clinical research","volume":"15","author":"Bardwell","year":"2021","journal-title":"J. Addict. Med."},{"issue":"3","key":"10.1016\/j.socscimed.2025.118697_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.drugpo.2006.07.001","article-title":"Positive and negative aspects of participation in illicit drug research: implications for recruitment and ethical conduct","volume":"18","author":"Barratt","year":"2007","journal-title":"Int. J. Drug Pol."},{"issue":"October 2021","key":"10.1016\/j.socscimed.2025.118697_bib4","article-title":"Pharmacists expanded role in providing care for opioid use disorder during COVID-19: a qualitative study exploring pharmacists' experiences","volume":"232","author":"Bishop","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"22","key":"10.1016\/j.socscimed.2025.118697_bib5","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMms1604593","article-title":"Assessing the Gold standard\u2014lessons from the history of RCTs","volume":"374","author":"Bothwell","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.socscimed.2025.118697_bib6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/00031224231209445","article-title":"Trojan horse technologies: smuggling criminal-legal logics into healthcare practice","volume":"88","author":"Chiarello","year":"2023","journal-title":"Am. Sociol. Rev."},{"key":"10.1016\/j.socscimed.2025.118697_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.healthplace.2016.06.005","article-title":"Navigating identity, territorial stigma, and HIV care services in Vancouver, Canada: a qualitative study","volume":"40","author":"Collins","year":"2016","journal-title":"Health Place"},{"issue":"8","key":"10.1016\/j.socscimed.2025.118697_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJMp2002908","article-title":"When prescribing isn't Enough\u2014pharmacy-level barriers to buprenorphine access","volume":"383","author":"Cooper","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.socscimed.2025.118697_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.drugpo.2014.03.004","article-title":"Integrating place into research on drug use, drug users' health, and drug policy","volume":"25","author":"Cooper","year":"2014","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2025.118697_bib10","series-title":"Clinical Labor: Tissue Donors and Research Subjects in the Global Bioeconomy","author":"Cooper","year":"2014"},{"issue":"9","key":"10.1016\/j.socscimed.2025.118697_bib11","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.socscimed.2007.05.036","article-title":"Understanding and representing \u201cplace\u201d in health research: a relational approach","volume":"65","author":"Cummins","year":"2007","journal-title":"Soc. Sci. Med."},{"issue":"6","key":"10.1016\/j.socscimed.2025.118697_bib12","first-page":"1521","article-title":"Contextualizing overdoses in Los Angeles's skid row between 2014 and 2016 by leveraging the spatial knowledge of the marginalized as a resource","volume":"108","author":"Curtis","year":"2018","journal-title":"Ann. Assoc. Am. Geogr."},{"key":"10.1016\/j.socscimed.2025.118697_bib13","article-title":"Flexible coding of In-depth interviews: a twenty-first-century approach","author":"Deterding","year":"2018","journal-title":"Socio. Methods Res."},{"issue":"5","key":"10.1016\/j.socscimed.2025.118697_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.drugpo.2015.01.004","article-title":"Streets, strolls and spots: sex work, drug use and social space in detroit","volume":"26","author":"Draus","year":"2015","journal-title":"Int. J. Drug Pol."},{"issue":"5","key":"10.1016\/j.socscimed.2025.118697_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/16066350601165448","article-title":"Towards a theory of drug use contexts: space, embodiment and practice","volume":"15","author":"Duff","year":"2007","journal-title":"Addiction Res. Theor."},{"issue":"6","key":"10.1016\/j.socscimed.2025.118697_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.drugpo.2011.09.005","article-title":"Reassembling (social) contexts: new directions for a sociology of drugs","volume":"22","author":"Duff","year":"2011","journal-title":"Int. J. Drug Pol."},{"issue":"4","key":"10.1016\/j.socscimed.2025.118697_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/016224399502000402","article-title":"The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials","volume":"20","author":"Epstein","year":"1995","journal-title":"Sci. Technol. Hum. Val."},{"issue":"5","key":"10.1016\/j.socscimed.2025.118697_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0306312708091930","article-title":"The rise of \u201crecruitmentology\u201d: clinical research, racial knowledge, and the politics of inclusion and difference","volume":"38","author":"Epstein","year":"2008","journal-title":"Soc. Stud. Sci."},{"key":"10.1016\/j.socscimed.2025.118697_bib19","series-title":"Medical Research for Hire: the Political Economy of Pharmaceutical Clinical Trials","author":"Fisher","year":"2009"},{"key":"10.1016\/j.socscimed.2025.118697_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.socscimed.2014.08.023","article-title":"Peering into the pharmaceutical \u201cpipeline\u201d: investigational drugs, clinical trials, and industry priorities","volume":"131","author":"Fisher","year":"2015","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2025.118697_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.soc.26.1.463","article-title":"A space for place in sociology","volume":"26","author":"Gieryn","year":"2000","journal-title":"Annu. Rev. Sociol."},{"issue":"6","key":"10.1016\/j.socscimed.2025.118697_bib22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/1049732311432718","article-title":"Methadone as social control: institutionalized stigma and the prospect of recovery","volume":"22","author":"Harris","year":"2012","journal-title":"Qual. Health Res."},{"key":"10.1016\/j.socscimed.2025.118697_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthplace.2019.102164","article-title":"From risky places to safe spaces: Re-assembling spaces and places in Vancouver's downtown eastside","volume":"59","author":"Ivsins","year":"2019","journal-title":"Health Place"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118697_bib55","article-title":"\"The hardest part of what we\u2019re doing\u201d: Research staff perspectives on engaging marginalized populations in substance use trials. Substan. Abuse Treat. Preven. Policy","volume":"20","author":"Jaffe","year":"2025"},{"issue":"8","key":"10.1016\/j.socscimed.2025.118697_bib56","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1177\/10497323211016408","article-title":"Experimental (re)structuring: The clinical trial as turning point among medical research participants","volume":"31","author":"Jaffe","year":"2021","journal-title":"Qualit. Health Res."},{"issue":"5","key":"10.1016\/j.socscimed.2025.118697_bib57","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/1467-9566.13297","article-title":"This could be my last chance\u2019: Therapeutic optimism in a randomised controlled trial for substance use disorders","volume":"43","author":"Jaffe","year":"2021","journal-title":"Soc. Health Illness"},{"key":"10.1016\/j.socscimed.2025.118697_bib58","doi-asserted-by":"crossref","first-page":"209134","DOI":"10.1016\/j.josat.2023.209134","article-title":"I thought it was for guys that did needles\u201d: Medication perceptions and lay expertise among medical research participants","volume":"154","author":"Jaffe","year":"2023","journal-title":"J. Subst. Use Addict. Treat."},{"issue":"12","key":"10.1016\/j.socscimed.2025.118697_bib24","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1177\/1049732318786703","article-title":"A guide to multisite qualitative analysis","volume":"28","author":"Jenkins","year":"2018","journal-title":"Qual. Health Res."},{"key":"10.1016\/j.socscimed.2025.118697_bib50","first-page":"1","article-title":"Flexible Buprenorphine\/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial","author":"Jutras-Aswad","year":"2022","journal-title":"Am. J. Psychiatr."},{"issue":"6","key":"10.1016\/j.socscimed.2025.118697_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.drugpo.2011.09.006","article-title":"The politics of visibility: drug users and the spaces of drug use","volume":"22","author":"Keane","year":"2011","journal-title":"Int. J. Drug Pol."},{"issue":"4","key":"10.1016\/j.socscimed.2025.118697_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/09581596.2013.873532","article-title":"Spatial stigma and health inequality","volume":"24","author":"Keene","year":"2014","journal-title":"Crit. Public Health"},{"issue":"4","key":"10.1016\/j.socscimed.2025.118697_bib27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.socscimed.2011.11.012","article-title":"Understanding the outcomes of multi-centre clinical trials: a qualitative study of health professional experiences and views","volume":"74","author":"Lawton","year":"2012","journal-title":"Soc. Sci. Med."},{"issue":"1","key":"10.1016\/j.socscimed.2025.118697_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0277-9536(01)00214-3","article-title":"Place effects on health: how can we conceptualise, operationalise and measure them?","volume":"55","author":"Macintyre","year":"2002","journal-title":"Soc. Sci. Med."},{"issue":"5","key":"10.1016\/j.socscimed.2025.118697_bib29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/1049732319831032","article-title":"Evaluating complex health interventions with randomized controlled trials: how do we improve the use of qualitative methods?","volume":"29","author":"Mannell","year":"2019","journal-title":"Qual. Health Res."},{"issue":"6","key":"10.1016\/j.socscimed.2025.118697_bib30","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s11524-015-9992-x","article-title":"Exploring the public health impacts of private security guards on people who use drugs: a qualitative study","volume":"92","author":"Markwick","year":"2015","journal-title":"J. Urban Health"},{"issue":"7","key":"10.1016\/j.socscimed.2025.118697_bib31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/1467-9566.12284","article-title":"Architecture and health care: a place for sociology","volume":"37","author":"Martin","year":"2015","journal-title":"Sociol. Health Illness"},{"key":"10.1016\/j.socscimed.2025.118697_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.socscimed.2014.01.010","article-title":"Hospitals as a \u201crisk environment\u201d: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs","volume":"105","author":"McNeil","year":"2014","journal-title":"Soc. Sci. Med."},{"issue":"4","key":"10.1016\/j.socscimed.2025.118697_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.23987\/sts.59226","article-title":"Clinical trials and the drive to material standardisation: \u201cextending the Rails\u201d or reinventing the wheel?","volume":"30","author":"Montgomery","year":"2017","journal-title":"Sci. Technol. Stud."},{"key":"10.1016\/j.socscimed.2025.118697_bib34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","article-title":"Stigma at every turn: health services experiences among people who inject drugs","volume":"57","author":"Paquette","year":"2018","journal-title":"Int. J. Drug Pol."},{"issue":"2","key":"10.1016\/j.socscimed.2025.118697_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.31887\/DCNS.2011.13.2\/npatsopoulos","article-title":"A pragmatic view on pragmatic trials","volume":"13","author":"Patsopoulos","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"issue":"394","key":"10.1016\/j.socscimed.2025.118697_bib36","first-page":"1","article-title":"Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy","volume":"16","author":"Pearce","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.socscimed.2025.118697_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102840","article-title":"Ranking evidence in substance use and addiction","volume":"83","author":"Reddon","year":"2020","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2025.118697_bib51","article-title":"Research Participation in Substance Use Disorder Trials: Design and Methods of a Multi-Site Nested Qualitative Study","volume":"21","author":"Richardson","year":"2022","journal-title":"Int. J. Qualitat. Meth."},{"key":"10.1016\/j.socscimed.2025.118697_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev.soc.25.1.489","article-title":"Socioeconomic position and health: the independent contribution of community socioeconomic context","volume":"25","author":"Robert","year":"1999","journal-title":"Annu. Rev. Sociol."},{"issue":"1","key":"10.1016\/j.socscimed.2025.118697_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/002214650905000104","article-title":"Neighborhood disorder, subjective alienation, and distress","volume":"50","author":"Ross","year":"2009","journal-title":"J. Health Soc. Behav."},{"issue":"8","key":"10.1016\/j.socscimed.2025.118697_bib40","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/1467-9566.12311","article-title":"Meeting pragmatism halfway: making a pragmatic clinical trial protocol","volume":"37","author":"Rushforth","year":"2015","journal-title":"Sociol. Health Illness"},{"key":"10.1016\/j.socscimed.2025.118697_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.102629","article-title":"Steps toward a theory of place effects on drug use: risk, marginality, and opportunity in small and remote California towns","volume":"85","author":"Showalter","year":"2020","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2025.118697_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cct.2018.04.001","article-title":"The OPTIMA study, buprenorphine\/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale","volume":"69","author":"Socias","year":"2018","journal-title":"Contem. Clin. Trial"},{"issue":"3","key":"10.1016\/j.socscimed.2025.118697_bib42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.drugpo.2014.02.012","article-title":"Living with addiction: the perspectives of drug using and non-using individuals about sharing space in a hospital setting","volume":"25","author":"Strike","year":"2014","journal-title":"Int. J. Drug Pol."},{"issue":"3","key":"10.1016\/j.socscimed.2025.118697_bib43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.drugpo.2013.12.010","article-title":"Remaking hospital space: the health care practices of injection drug users in New York city","volume":"25","author":"Szott","year":"2014","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.socscimed.2025.118697_bib44","series-title":"Abductive Analysis: Theorizing Qualitative Research","author":"Tavory","year":"2014"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118697_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.drugpo.2008.02.002","article-title":"Drugscapes and the role of place and space in injection drug use-related HIV risk environments","volume":"20","author":"Tempalski","year":"2009","journal-title":"Int. J. Drug Pol."},{"issue":"1","key":"10.1016\/j.socscimed.2025.118697_bib46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.soc.012809.102629","article-title":"A world of standards but not a standard world: toward a sociology of standards and standardization","volume":"36","author":"Timmermans","year":"2010","journal-title":"Annu. Rev. Sociol."},{"issue":"2","key":"10.1016\/j.socscimed.2025.118697_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/1467-9566.12105","article-title":"A relational approach to health practices: towards transcending the agency-structure divide","volume":"36","author":"Veenstra","year":"2014","journal-title":"Sociol. Health Illness"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118697_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/0725513607082003","article-title":"Territorial stigmatization in the age of advanced marginality","volume":"91","author":"Wacquant","year":"2007","journal-title":"Thesis Eleven"},{"issue":"4","key":"10.1016\/j.socscimed.2025.118697_bib49","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/soin.12228","article-title":"Captive to the clinic: phase I clinical trials as temporal total institutions","volume":"88","author":"Williams","year":"2018","journal-title":"Sociol. Inq."}],"container-title":["Social Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953625010287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953625010287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:24:54Z","timestamp":1780820694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0277953625010287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":58,"alternative-id":["S0277953625010287"],"URL":"https:\/\/doi.org\/10.1016\/j.socscimed.2025.118697","relation":{},"ISSN":["0277-9536"],"issn-type":[{"value":"0277-9536","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cTrying to get down here when the dealer's closer\u201d: Place and participation in clinical trials for substance use disorders","name":"articletitle","label":"Article Title"},{"value":"Social Science & Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.socscimed.2025.118697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118697"}}